KEGG: pgu:PGUG_05495
STRING: 4929.A5DQE4
Recombinant MCR1 from M. guilliermondii is a 294-amino acid protein (UniProt: A5DQE4) with a Tris-based buffer formulation (50% glycerol) optimized for stability under cryoconditions (-20°C or -80°C) . Its enzymatic activity is defined by EC 1.6.2.2, catalyzing electron transfer from NADH to cytochrome b5 . Structural analyses reveal conserved motifs critical for redox function, including hydrophilic and hydrophobic domains that mediate substrate binding and electron shuttling.
Methodological Insight: For structural studies, X-ray crystallography or cryo-EM could map active-site residues, while mutagenesis (e.g., alanine scanning) could identify catalytic hotspots. Functional assays should include spectrophotometric monitoring of cytochrome b5 reduction kinetics under varying pH/temperature conditions .
MCR1 is implicated in biocontrol via stress-response pathways and organic waste degradation. In M. guilliermondii CECT13190, MCR1 contributes to pathogen antagonism by modulating oxidative stress and nutrient competition . Its role in composting (e.g., strain vka1) involves macromolecule degradation, enabled by co-expressed hydrolases and transporters .
Methodological Insight: Functional screens should integrate secretome profiling (e.g., LC-MS) to identify MCR1-associated proteins (e.g., HSP70, HSP90) and their synergistic roles in biocontrol . Comparative genomics across M. guilliermondii strains could reveal MCR1 orthologs with enhanced biodegradation potential .
The draft genome of M. guilliermondii vka1 spans 10.8 Mb with 5,385 genes, including MCR1 orthologs . Phylogenetic analysis places it within Ascomycota, with unique gene clusters linked to lignocellulose breakdown and stress adaptation . MCR1’s genomic context may involve synteny with other redox enzymes, suggesting regulatory co-expression.
Methodological Insight: De novo assembly using hybrid sequencing (Illumina + Nanopore) is recommended for resolving repetitive regions. Functional annotation should prioritize KEGG/GO enrichment for redox pathways and validate orthologs via reciprocal BLAST against S. cerevisiae or Candida spp. .
To elucidate MCR1’s mechanisms, researchers should employ:
Gene Knockout/Overexpression: CRISPR-Cas9 editing to test MCR1’s necessity in biocontrol or composting.
Secretome Profiling: LC-MS identification of MCR1-co-secreted proteins (e.g., HSPs, esterases) under stress .
CNV Analysis: Whole-genome sequencing to detect copy number variations correlating with fitness in microbial communities .
Data Contradiction: While CNV gains in stress-response genes (e.g., HSPs) enhance survival, losses in catabolic genes may reduce metabolic versatility .
In M. guilliermondii CECT13190, CNV analysis revealed seven gene gains (e.g., stress-response proteins) and five losses (e.g., glutamate synthase). These variations correlate with competitive fitness in resource-limited environments .
| Gene Class | CNV Type | Functional Impact |
|---|---|---|
| Stress-Response Proteins | Gains | Enhanced survival under oxidative stress |
| Transporters (OPT family) | Gains | Improved nutrient uptake efficiency |
| Metabolic Enzymes | Losses | Reduced substrate utilization |
Methodological Insight: CNV detection requires Illumina paired-end sequencing (>100× coverage) with tools like CNVnator. Functional validation should include growth assays under manganese or pH stress .
De novo assembly of M. guilliermondii genomes faces challenges in resolving repetitive regions and annotating non-model yeast genes. Hybrid sequencing (Illumina + Nanopore) improves contiguity but requires computational resources for scaffolding .
Methodological Insight: Annotation pipelines should prioritize:
Protein Homology: BLAST alignment against S. cerevisiae proteomes.
Domain Prediction: Pfam/InterPro for redox-active motifs.
Comparative Genomics: OrthoFinder for strain-specific gene clusters .
MCR1’s secretome includes HSP70 and HSP90, which likely modulate pathogen membrane integrity or trigger host immune responses . These proteins may act synergistically with MCR1 to induce oxidative stress in fungal pathogens.
Co-IP Mass Spectrometry: Identify MCR1-interacting proteins.
Gene Deletion: Test HSP70/HSP90 knockouts for biocontrol efficacy.
ROS Assays: Quantify reactive oxygen species (ROS) during MCR1-pathogen interactions .
Recombinant MCR1 activity should be validated via:
Spectrophotometry: Monitor cytochrome b5 reduction at 550 nm (Δε = 29.1 mM⁻¹ cm⁻¹).
Substrate Specificity: Test NADH, FAD, or alternative electron donors.
Thermostability: Measure activity at 4°C–40°C to assess cold adaptation .
Control Groups: Include cytochrome b5 alone (negative control) and NADH-cytochrome b5 reductase from H. sapiens (positive control) .
Comparing M. guilliermondii strains (e.g., vka1 vs. CECT13190) can identify MCR1 paralogs with enhanced biodegradation or stress resistance.
Ortholog Clustering: Use OrthoMCL to group MCR1 variants.
Site-Directed Mutagenesis: Test conserved residues (e.g., Zn²⁺-chelating motifs) for catalytic efficiency .
MCR1-associated HSPs (e.g., HSP70) may stabilize industrial enzymes under harsh conditions (e.g., high salt, low pH). Overexpression in M. guilliermondii could enhance bioremediation efficacy in contaminated soils .